InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Angulo Gonzalez David, Directeur Médical. Insider active across 1 company, notably SCYNEXIS INC. Aggregated, 10 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €25k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 29 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Angulo Gonzalez David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
108,695 sharesCommon StockSEC:0001644071-26-000002:0
Canonical exit: 30 Jun 2026 (T+90)
391,333 shares0Common StockSEC:0001178253-26-000003:0
32,500 shares@ US$0.7630.9% of flowCommon StockSEC:0001178253-25-000007:0
23,000 shares@ US$0.8425.8% of flowCommon StockSEC:0000950170-25-052675:0
5,000 shares@ US$1.077.2% of flowCommon StockSEC:0000950170-25-042838:0
262,927 shares0Common StockSEC:0000950170-25-009170:0
20,000 shares@ US$1.3736.2% of flowCommon StockSEC:0000950170-24-106610:0
Canonical exit: 11 Dec 2024 (T+90)
290,590 shares0Common StockSEC:0000950170-24-008808:0
110,000 shares0Common StockSEC:0001209191-23-000155:0
51,100 shares0Common StockSEC:0001209191-22-007727:0
10 of 10 declarations
About Angulo Gonzalez David
Angulo Gonzalez David is Directeur Médical and Chief Executive Officer at SCYNEXIS INC (XNAS). He has 10 filings in total, and across the sampled recent filings from 2022-02-08 to 2026-04-02, buys total EUR 24734 and no sales are reported; the most common transaction nature is Attribution.
